Technical Analysis for SIBN - SI-BONE, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Historical SIBN trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | -1.26% | |
Outside Day | Range Expansion | -1.26% | |
NR7 | Range Contraction | 1.63% | |
Bearish Engulfing | Bearish | -0.15% | |
Doji - Bearish? | Reversal | -0.15% | |
Outside Day | Range Expansion | -0.15% | |
NR7 | Range Contraction | -0.44% | |
Doji - Bearish? | Reversal | -0.44% | |
Upper Bollinger Band Touch | Strength | -0.44% | |
20 DMA Support | Bullish | 5.39% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 2 % | about 2 hours ago |
Rose Above Previous Day's High | about 3 hours ago |
Down 1% | about 3 hours ago |
Rose Above Previous Day's High | about 22 hours ago |
Outside Day | about 22 hours ago |
Get a Trading Assistant
- Earnings date: 05/03/2021
SI-BONE, Inc. Description
SI-BONE is a medical device company that pioneered the iFuse Implant System, a minimally invasive surgical system for fusion of the sacroiliac joint to treat sacroiliac joint dysfunction. The SI joint is believed to be the last major joint with a clinically proven surgical treatment. The iFuse Implant, commercially available since 2009, is believed to be the only SI joint fusion device supported by multiple prospective clinical studies showing improved pain, patient function and quality of life resulting from treatment. There are over 60 peer-reviewed publications supporting the safety, effectiveness, and biomechanical and economic benefits unique to the iFuse Implant. This body of evidence has enabled multiple government and private payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Bone Dysfunction Prosthetics Quality Of Life Implant Minimally Invasive Procedures Surgical Treatment Pelvis Joint Dysfunction Medical Classification Medical Subject Headings Sacroiliac Joint
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 35.68 |
52 Week Low | 13.05 |
Average Volume | 286,998 |
200-Day Moving Average | 25.25 |
50-Day Moving Average | 31.69 |
20-Day Moving Average | 32.34 |
10-Day Moving Average | 32.76 |
Average True Range | 1.60 |
ADX | 12.78 |
+DI | 25.97 |
-DI | 18.99 |
Chandelier Exit (Long, 3 ATRs ) | 30.89 |
Chandelier Exit (Short, 3 ATRs ) | 33.78 |
Upper Bollinger Band | 34.91 |
Lower Bollinger Band | 29.76 |
Percent B (%b) | 0.83 |
BandWidth | 15.95 |
MACD Line | 0.62 |
MACD Signal Line | 0.43 |
MACD Histogram | 0.1825 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 36.28 | ||||
Resistance 3 (R3) | 36.07 | 35.12 | 35.90 | ||
Resistance 2 (R2) | 35.12 | 34.55 | 35.22 | 35.78 | |
Resistance 1 (R1) | 34.58 | 34.20 | 34.85 | 34.79 | 35.65 |
Pivot Point | 33.63 | 33.63 | 33.77 | 33.73 | 33.63 |
Support 1 (S1) | 33.09 | 33.06 | 33.36 | 33.30 | 32.43 |
Support 2 (S2) | 32.14 | 32.71 | 32.24 | 32.30 | |
Support 3 (S3) | 31.60 | 32.14 | 32.18 | ||
Support 4 (S4) | 31.81 |